SightfileU.S. market data from official filings

Companies › TRDA

ENTRADA THERAPEUTICS INC (TRDA)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001689375 · EDGAR filings · Updated 2026-06-12

ENTRADA THERAPEUTICS INC (TRDA) has reported institutional ownership of 65.6%, with 119 institutional managers holding positions valued at $321.4M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
65.6%
Institutional managers
119
Reported 13F value
$321.4M
Insider activity
59 trans.
−$3.91M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ENTRADA THERAPEUTICS INC has 119 institutional holders and institutional ownership of 65.6%.

Insider activity

Insiders reported 59 transactions (18 buys, 24 sells) across 11 reporting insiders, with a net reported value of −$3.91M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2022-03-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

PERSPECTIVE THERAPEUTICS INC (CATX) · OMEROS (OMER) · ATEA PHARMACEUTICALS INC (AVIR) · VANDA PHARMACEUTICALS INC (VNDA) · COMMUNITY HEALTH SYS INC NEW (CYH) · XOMA ROYALTY CORPORATION (XOMA)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-12.